Cory Randall Ellspermann's Insider Trades & SAST Disclosures

Cory Randall Ellspermann's most recent trade in INmune Bio Inc was a trade of 300,000 Option (right to buy) done . Disclosure was reported to the exchange on Dec. 1, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
INmune Bio Inc
Cory Randall Ellspermann CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2025 300,000 300,000 - - Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2025 75,000 75,000 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2025 75,000 0 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2025 70,000 70,000 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2025 70,000 0 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2025 40,000 40,000 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2025 40,000 0 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2025 30,000 30,000 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2025 30,000 0 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2025 30,000 30,000 - - Stock Option (right to buy)
INmune Bio Inc
Cory Randall Ellspermann Interim CFO Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2025 30,000 0 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades